Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE)

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-2652

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE) ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1-2 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1-2, 12.2008

Creator: Absalon, J.

Contributor: Thal, G.
Thiry, A.
Yang, R.
Mancini, MD
McGrath, D.
SpringerLink (Online service)

DOI: 10.1186/1758-2652-11-S1-P136

URN: urn:nbn:de:1111-2016052055964

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Absalon, J.
Thal, G.
Thiry, A.
Yang, R.
Mancini, MD
McGrath, D.
SpringerLink (Online service)

Other Objects (12)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Therapeutic vaccines in HBV: lessons from HCV

HIV lamivudine resistance mutations in HBV co-infected Romanian patients

HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Therapeutic vaccines in HBV: lessons from HCV

HIV lamivudine resistance mutations in HBV co-infected Romanian patients

HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Therapeutic vaccines in HBV: lessons from HCV

HIV lamivudine resistance mutations in HBV co-infected Romanian patients

HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE)

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Therapeutic vaccines in HBV: lessons from HCV

HIV lamivudine resistance mutations in HBV co-infected Romanian patients

HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Therapeutic vaccines in HBV: lessons from HCV

HIV lamivudine resistance mutations in HBV co-infected Romanian patients

HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Therapeutic vaccines in HBV: lessons from HCV

HIV lamivudine resistance mutations in HBV co-infected Romanian patients

HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

Related objects

Reset password